You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

doxorubicin

Showing 1 - 25 of 498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • LB-100 plus Doxorrubicin
  • Doxorubicin
  • (no location specified)
Apr 11, 2023

Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Los Angeles, California
    Sarcoma Oncology Center
Oct 16, 2023

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

Not yet recruiting
  • Breast Cancer Stage 2 and 3
  • (no location specified)
Nov 24, 2023

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 25, 2023

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Brain Tumor Trial in Washington (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Jan 4, 2023

Brain Tumor Trial in Toronto (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 5, 2023

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)

Completed
  • Breast Cancer
  • New York, New York
    Columbia University Medical Center
Oct 13, 2022

Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child Trial in Charlotte (Pembrolizumab, Doxorubicin)

Active, not recruiting
  • Soft Tissue Sarcoma, Adult
  • Soft Tissue Sarcoma, Child
  • Charlotte, North Carolina
    Levine Cancer Institute
Sep 29, 2022

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Doxorubicin
  • +3 more
  • Nicosia, Cyprus
  • +1 more
Jul 1, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

Not yet recruiting
  • Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 19, 2022

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Soft Tissue Sarcoma Trial in Worldwide (Onfekafusp alfa, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma
  • Onfekafusp alfa
  • Doxorubicin
  • Bad Saarow, Germany
  • +8 more
Apr 8, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)

Active, not recruiting
  • Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Research Center (SORC) Cancer Center of Souther
Apr 19, 2022

Metastatic Soft-tissue Sarcoma Trial in United States (NOX66, Doxorubicin)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Duarte, California
  • +3 more
Jul 12, 2022